Molecular Classification
Bacterial antigen complex, Other
Other Names
C. difficile surface antigens, C. difficile whole-cell lysate, C. difficile vegetative cell antigens, C. difficile spore and cell antigens, Clostridioides difficile antigens
Disease Roles
InfectionClostridioides difficile infection (CDI)Diarrhea

Clostridioides difficile cell-surface antigens and lysate components Overview

Clostridioides difficile cell-surface antigens and lysate components comprise a diverse array of molecular targets found on the surface and within the vegetative cells and spores of the bacterium Clostridioides difficile. These targets include surface-layer proteins (SLPs), cell wall proteins (Cwps), flagellar components, and various intracellular proteins released during cell lysis, alongside the critical virulence factor Toxin B (TcdB). Biologically, these components are vital for the bacterium's lifecycle, facilitating adherence to the intestinal mucosa, colonization of the gut, and the initiation of inflammatory processes through toxin secretion. In clinical settings, C. difficile is the primary cause of antibiotic-associated diarrhea and can lead to severe conditions such as pseudomembranous colitis and toxic megacolon. Therapeutic interventions, such as the oral polyclonal antibody IMM-529, are designed to target this broad spectrum of antigens to neutralize toxins and inhibit bacterial colonization. By addressing multiple stages of the infection cycle, these therapies aim to treat active disease and prevent the high rates of recurrence characteristic of C. difficile infections while sparing the host's beneficial gut microbiota.

Mechanism of Action

Polyclonal antibody-mediated neutralization of toxins (specifically Toxin B), inhibition of bacterial adhesion to intestinal epithelium, and prevention of spore-mediated colonization and germination.

Biological Functions

Adhesion
Colonization
Virulence
Toxin production
Spore germination

Disease Associations

Infection
Clostridioides difficile infection (CDI)
Diarrhea
Colitis

Safety Considerations

  • Allergic reactions to bovine-derived proteins
  • Potential for lack of efficacy in severe systemic disease due to oral administration
  • Therapeutic challenge of ensuring broad cross-reactivity across diverse hypervirulent strains

Interacting Drugs

IMM-529

Associated Biomarkers

Biomarker
Anti-C. difficile IgG titers
Anti-C. difficile IgA titers
Toxin B levels
C. difficile colonization levels